ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Neuromusculoskeletal Medicine, Sports Medicine

Top Neuromusculoskeletal Medicine, Sports Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WORKU ZEWDU M.D.

Neuromusculoskeletal Medicine, Sports Medicine

5,729

$142K

226
212 are 65+

15%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$25
Average prescription price

Avg: $123

RICHARD BROWN DO

Neuromusculoskeletal Medicine, Sports Medicine

4,779

$312K

256
185 are 65+

11%
patients receiving schedule two controlled substances

Avg: 11%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $123

MARSHALL KEILSON MD

Neuromusculoskeletal Medicine, Sports Medicine

4,327

$1.86M

466
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 25%

$430
Average prescription price

Avg: $123

MARC CIMMINO D.O.

Neuromusculoskeletal Medicine, Sports Medicine

2,640

$200K

199
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

6%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$76
Average prescription price

Avg: $123

GERALD LEVENTHAL M.D.

Neuromusculoskeletal Medicine, Sports Medicine

1,782

$145K

149
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$81
Average prescription price

Avg: $123

ALAN ZIMMERMAN M.D.

Neuromusculoskeletal Medicine, Sports Medicine

1,480

$92.6K

91
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $123

BARRY SLOAN D.O.

Neuromusculoskeletal Medicine, Sports Medicine

1,401

$210K

115
41 are 65+

52%
patients receiving schedule two controlled substances

Avg: 11%

10%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$150
Average prescription price

Avg: $123

TRACY ONAL D.O.

Neuromusculoskeletal Medicine, Sports Medicine

1,392

$91.6K

253
211 are 65+

5%
patients receiving schedule two controlled substances

Avg: 11%

7%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $123

DOROTHEA BADENHAUSEN M.D.

Neuromusculoskeletal Medicine, Sports Medicine

1,033

$49.4K

48
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $123

ARIC HAUSKNECHT MD

Neuromusculoskeletal Medicine, Sports Medicine

440

$30.7K

115
50 are 65+

17%
patients receiving schedule two controlled substances

Avg: 11%

23%
patients receiving schedule three controlled substances

Avg: 8%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $123

ORSUVILLE CABATU MD

Neuromusculoskeletal Medicine, Sports Medicine

357

$20.7K

73
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $123

GINA PENZI LUXEMBERG D.O.

Neuromusculoskeletal Medicine, Sports Medicine

323

$49.3K

65
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 25%

$153
Average prescription price

Avg: $123

WILLIAM THOMPSON M.D.

Neuromusculoskeletal Medicine, Sports Medicine

240

$8,048

111
97 are 65+

37%
patients receiving schedule two controlled substances

Avg: 11%

14%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $123

DONALD NENNO MD

Neuromusculoskeletal Medicine, Sports Medicine

214

$3,703

89
43 are 65+

15%
patients receiving schedule two controlled substances

Avg: 11%

38%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $123

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank